The FirstTake Podcast – Sanofi’s breast cancer hopeful fails to deliver
Update: 2022-03-17
Description
On this week’s episode FirstWord Pharma PLUS editors Virginia Li and Simon King discuss an unexpected corporate re-manoeuvring around Biogen and Eisai’s controversial Alzheimer’s drug Aduhelm and disappointing clinical data for Sanofi’s breast cancer drug amcenestrant. Simon also catches up with FirstWord HealthTech’s executive editor Tina Tan to find out about some recent oncologist surveys looking at the use of digital technologies to help combat pandemic-extended treatment waiting times and the mental wellbeing of cancer patients.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
